Radiation modulates the peptide repertoire, enhances MHC class I expression, and induces successful antitumor immunotherapy
Open accessThe DOI matches its Crossref record; 54 of the 54 references it cites were found in a registry or an index.
Abstract
Radiotherapy is one of the most successful cancer therapies. Here the effect of irradiation on antigen presentation by MHC class I molecules was studied. Cell surface expression of MHC class I molecules was increased for many days in a radiation dose-dependent manner as a consequence of three responses. Initially, enhanced degradation of existing proteins occurred which resulted in an increased intracellular peptide pool. Subsequently, enhanced translation due to activation of the mammalian target of rapamycin pathway resulted in increased peptide production, antigen presentation, as well as cytotoxic T lymphocyte recognition of irradiated cells. In addition, novel proteins were made in response to gamma-irradiation, resulting in new peptides presented by MHC class I molecules, which were recognized by cytotoxic T cells. We show that immunotherapy is successful in eradicating a murine colon adenocarcinoma only when preceded by radiotherapy of the tumor tissue. Our findings indicate that directed radiotherapy can improve the efficacy of tumor immunotherapy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures






Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“irradiation can also increase tumor antigenicity through enriching the pool of antigenic peptides”
From Hallmarks of response, resistance, and toxicity to immune checkpoint blockade (2021) · cites this paper as Reits et al., 2006
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
In silico prediction of protein-protein interactions in human macrophages
Souiai, O., Guerfali, F., Ben Miled, S., Brun, C., & Benkahla, A. (2014) · BMC Research Notes · doi:10.1186/1756-0500-7-157 · Cited by 10,803
Significance analysis of microarrays applied to the ionizing radiation response
Tusher, V. G., Tibshirani, R., & Chu, G. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.091062498 · Cited by 10,568
Phenotypic Analysis of Antigen-Specific T Lymphocytes
Altman, J. D., Moss, P. A. H., Goulder, P. J. R., Barouch, D. H., McHeyzer-Williams, M. G., Bell, J. I., McMichael, A. J., & Davis, M. M. (1996) · Science · doi:10.1126/science.274.5284.94 · Cited by 3,544 · cited 1×
“folding the HLA-A1 heavy chain with peptides CGI-51(206–215), MSH6(469–478), and F-box protein Fbl7(335–362) and human β2m as described (51).”
BackgroundDNA double-strand breaks: signaling, repair and the cancer connection
Khanna, K. K., & Jackson, S. P. (2001) · Nature Genetics · doi:10.1038/85798 · Cited by 2,455
Rapid degradation of a large fraction of newly synthesized proteins by proteasomes
Schubert, U., Antón, L. C., Gibbs, J., Norbury, C. C., Yewdell, J. W., & Bennink, J. R. (2000) · Nature · doi:10.1038/35008096 · Cited by 1,536
Error-Tolerant Identification of Peptides in Sequence Databases by Peptide Sequence Tags
Mann, M., & Wilm, M. (1994) · Analytical Chemistry · doi:10.1021/ac00096a002 · Cited by 1,468
Ionizing radiation inhibition of distant untreated tumors (abscopal effect) is immune mediated
Demaria, S., Ng, B., Devitt, M. L., Babb, J. S., Kawashima, N., Liebes, L., & Formenti, S. C. (2004) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2003.09.012 · Cited by 1,388
Fingar, D. C., & Blenis, J. (2004) · Oncogene · doi:10.1038/sj.onc.1207542 · Cited by 1,247
Characterization of circulating T cells specific for tumor-associated antigens in melanoma patients
Lee, P. P., Yee, C., Savage, P. A., Fong, L., Brockstedt, D., Weber, J. S., Johnson, D., Swetter, S., Thompson, J., Greenberg, P. D., et al. (1999) · Nature Medicine · doi:10.1038/9525 · Cited by 1,113
Lugade, A. A., Moran, J. P., Gerber, S. A., Rose, R. C., Frelinger, J. G., & Lord, E. M. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.174.12.7516 · Cited by 966 · cited 3×
“This is probably not due only to up-regulation of MHC class I expression because mTOR activation will have more general eff ects on protein expression including up-regulation of Fas, ICAM-1 (38), and interferon expression (33, 34).”
Background
Research works printed but not linked: 5
- 2000, Oncology (Huntingt), 14, 741
- 1988, Nippon Igaku Hoshasen Gakkai Zasshi., 48, 1572
- 2000, Anticancer Res., 20, 3375
- 2002, Cancer Res., 62, 1462
- 1991, Cancer Res., 51, 3657
Cited by
Items 301–400 of 1,000
Immune Checkpoint Inhibitors in Brain Metastases: From Biology to Treatment
Berghoff, A. S., Venur, V. A., Preusser, M., & Ahluwalia, M. S. (2016) · American Society of Clinical Oncology Educational Book · doi:10.1200/edbk_100005 · Cited by 106
Assessing the future of solid tumor immunotherapy
Guha, P., Heatherton, K. R., O’Connell, K. P., Alexander, I. S., & Katz, S. C. (2022) · Biomedicines · doi:10.3390/biomedicines10030655 · Cited by 105
Immunomodulatory Effects of Radiotherapy
Kumari, S., Mukherjee, S., Sinha, D., Abdisalaam, S., Krishnan, S., & Asaithamby, A. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21218151 · Cited by 106
Cortiula, F., Reymen, B. J. T., Peters, S., Mol, P. V., Wauters, E., Vansteenkiste, J., Ruysscher, D. D., & Hendriks, L. E. L. (2022) · Annals of Oncology · doi:10.1016/j.annonc.2022.06.013 · Cited by 105
Federico, A. D., Rizzo, A., Carloni, R., Giglio, A. D., Bruno, R., Ricci, D., & Brandi, G. (2021) · Expert Opinion on Investigational Drugs · doi:10.1080/13543784.2022.2009455 · Cited by 105
Chapuis, A. G., Afanasiev, O. K., Iyer, J. G., Paulson, K. G., Parvathaneni, U., Hwang, J. H., Lai, I. P., Roberts, I. M., Sloan, H. L., Bhatia, S., et al. (2013) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-13-0087 · Cited by 104
Kirsch, D. G., Diehn, M., Kesarwala, A. H., Maity, A. M., Morgan, M. A., Schwarz, J. K., Bristow, R. G., Demaria, S., Eke, I., Griffin, R. J., et al. (2017) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djx231 · Cited by 102
Jones, K. I., Tiersma, J. F., Yuzhalin, A. E., Gordon-Weeks, A. N., Buzzelli, J. N., Im, J. H., & Muschel, R. J. (2018) · EMBO Molecular Medicine · doi:10.15252/emmm.201809342 · Cited by 102
Tumor microenvironment modulation enhances immunologic benefit of chemoradiotherapy
Hanoteau, A., Newton, J. M., Krupar, R., Huang, C. L., Liu, H., Gaspero, A., Gartrell, R. D., Saenger, Y. M., Hart, T. D., Santegoets, S. J. A. M., et al. (2019) · Journal for ImmunoTherapy of Cancer · doi:10.1186/s40425-018-0485-9 · Cited by 102
Fite, B. Z., Wang, J., Kare, A. J., Ilovitsh, A., Chavez, M., Ilovitsh, T., Zhang, N., Chen, W., Robinson, E. R., Zhang, H., et al. (2021) · Scientific Reports · doi:10.1038/s41598-020-80135-1 · Cited by 104
Regulatory T Cells in Radiotherapeutic Responses
Schaue, D., Xie, M. W., Ratikan, J. A., & McBride, W. H. (2012) · Frontiers in Oncology · doi:10.3389/fonc.2012.00090 · Cited by 103
Enhancing immunotherapy using chemotherapy and radiation to modify the tumor microenvironment
Kershaw, M. H., Devaud, C., John, L. B., Westwood, J. A., & Darcy, P. K. (2013) · OncoImmunology · doi:10.4161/onci.25962 · Cited by 102
The role of macrophage phenotype in regulating the response to radiation therapy
Shi, X., & Shiao, S. L. (2017) · Translational research · doi:10.1016/j.trsl.2017.11.002 · Cited by 102
Radiation Therapy and the In Situ Vaccination Approach
Golden, E. B., Marciscano, A. E. E., & Formenti, S. C. (2020) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2020.08.023 · Cited by 101
Radiation-inducible Immunotherapy for Cancer: Senescent Tumor Cells as a Cancer Vaccine
Meng, Y., Efimova, E. V., Hamzeh, K. W., Darga, T. E., Mauceri, H. J., Fu, Y.-X., Kron, S. J., & Weichselbaum, R. R. (2012) · Molecular Therapy · doi:10.1038/mt.2012.19 · Cited by 94
Marciscano, A. E. E., Haimovitz‐Friedman, A., Lee, P. P., Tran, P. T., Tomé, W. A., Guha, C., Kong, F., Sahgal, A., Naqa, I. E., Rimner, A., et al. (2019) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2019.02.046 · Cited by 100
Trials and tribulations of pancreatic cancer immunotherapy
Principe, D. R., Korc, M., Kamath, S. D., Munshi, H. G., & Rana, A. (2021) · Cancer Letters · doi:10.1016/j.canlet.2021.01.031 · Cited by 100
Reits, E. A., Hodge, J. W., Herberts, C. A., Groothuis, T. A., Chakraborty, M., Wansley, E. K., Camphausen, K. A., Luiten, R. M., de Ru, A. H., Neijssen, J., et al. (2006) · The Journal of Cell Biology · doi:10.1083/jcb1734oia6 · Cited by 100
Self-citationVaccines based on whole recombinant Saccharomyces cerevisiae cells
Ardiani, A., Higgins, J. P., & Hodge, J. W. (2010) · FEMS Yeast Research · doi:10.1111/j.1567-1364.2010.00665.x · Cited by 99
Self-citationChallenges and prospects of immunotherapy as cancer treatment
Rescigno, M., Avogadri, F., & Curigliano, G. (2007) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2007.07.003 · Cited by 100
Metastases in Immune-Mediated Dormancy: A New Opportunity for Targeting Cancer
Romero, I., Garrido, F., & Garcia-Lora, A. M. (2014) · Cancer Research · doi:10.1158/0008-5472.can-14-2406 · Cited by 86
Colton, M., Cheadle, E. J., Honeychurch, J., & Illidge, T. (2020) · Radiation Oncology · doi:10.1186/s13014-020-01678-1 · Cited by 98
A Review of the Abscopal Effect in the Era of Immunotherapy
Nabrinsky, E., Macklis, J. N., & Bitran, J. D. (2022) · Cureus · doi:10.7759/cureus.29620 · Cited by 98
Space Radiation Protection Countermeasures in Microgravity and Planetary Exploration
Montesinos, C. A., Khalid, R., Cristea, O., Greenberger, J. S., Epperly, M. W., Lemon, J. A., Boreham, D. R., Popov, D., Gorthi, G., Ramkumar, N., et al. (2021) · Life · doi:10.3390/life11080829 · Cited by 98
Epigenetic regulation of differentialHLA-Aallelic expression levels
Ramsuran, V., Kulkarni, S., Ó’hUigín, C., Yuki, Y., Augusto, D. G., Gao, X., & Carrington, M. N. (2015) · Human Molecular Genetics · doi:10.1093/hmg/ddv158 · Cited by 97
Radiotherapy and immunotherapy: a synergistic effect in cancer care
Turgeon, G., Weickhardt, A. J., Azad, A., Solomon, B., & Siva, S. (2018) · The Medical Journal of Australia · doi:10.5694/mja2.12046 · Cited by 97
Tumor microenvironment and immune-related therapies of head and neck squamous cell carcinoma
Qin, Y., Zheng, X., Gao, W., Wang, B., & Wu, Y. (2021) · Molecular Therapy — Oncolytics · doi:10.1016/j.omto.2021.01.011 · Cited by 96
Harnessing the immune response to treat cancer
Steer, H. J., Lake, R., Nowak, A. K., & Robinson, B. W. S. (2010) · Oncogene · doi:10.1038/onc.2010.437 · Cited by 97
Habashy, K. J., Mansour, R., Moussalem, C., Sawaya, R., & Massaad, M. J. (2022) · British Journal of Cancer · doi:10.1038/s41416-022-01864-w · Cited by 95
Fiedler, K., Lazzaro, S., Lutz, J., Rauch, S., & Heidenreich, R. (2016) · Recent results in cancer research/Recent Results in Cancer Research · doi:10.1007/978-3-319-42934-2_5 · Cited by 97
Melatonin as an anti-inflammatory agent in radiotherapy
Najafi, M., Shirazi, A., Motevaseli, E., Rezaeyan, A., Salajegheh, A., & Rezapoor, S. (2017) · Inflammopharmacology · doi:10.1007/s10787-017-0332-5 · Cited by 95
PANVAC™-VF: poxviral-based vaccine therapy targeting CEA and MUC1 in carcinoma
Madan, R. A., Arlen, P. M., & Gulley, J. L. (2007) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.7.4.543 · Cited by 89
Demaria, S., Pilones, K. A., Vanpouille‐Box, C., Golden, E. B., & Formenti, S. C. (2014) · Radiation Research · doi:10.1667/rr13500.1 · Cited by 95
Radiotherapy augments the immune response to prostate cancer in a time‐dependent manner
Harris, T. J., Hipkiss, E. L., Borzillary, S., Wada, S., Grosso, J. F., Yen, H., Getnet, D., Bruno, T. C., Goldberg, M. V., Pardoll, D. M., et al. (2008) · The Prostate · doi:10.1002/pros.20794 · Cited by 95
Simone, C. B., Burri, S. H., & Heinzerling, J. H. (2015) · PubMed Central · doi:10.3978/j.issn.2218-6751.2015.10.05 · Cited by 95
Ogiya, R., Niikura, N., Kumaki, N., Yasojima, H., Iwasa, T., Kanbayashi, C., Oshitanai, R., Tsuneizumi, M., Watanabe, K., Matsui, A., et al. (2017) · Oncotarget · doi:10.18632/oncotarget.22110 · Cited by 94
Li, H., Yang, Z., & Guo, Q. (2021) · Cell Communication and Signaling · doi:10.1186/s12964-021-00789-w · Cited by 95
Effects of Radiation on the Tumor Microenvironment
Monjazeb, A. M., Schalper, K. A., Villarroel‐Espíndola, F., Nguyen, A. T., Shiao, S. L., & Young, K. H. (2020) · Seminars in Radiation Oncology · doi:10.1016/j.semradonc.2019.12.004 · Cited by 93
Targeting Radiation-Resistant Prostate Cancer Stem Cells by B7-H3 CAR T Cells
Zhang, Y., He, L., Sadagopan, A., Ma, T., Dotti, G., Wang, Y., Zheng, H., Gao, X. Y., Wang, D., DeLeo, A. B., et al. (2021) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-20-0446 · Cited by 93
Ludmir, E. B., Sherry, A. D., Fellman, B. M., Liu, S., Bathala, T. K., Haymaker, C., Medina-Rosales, M. N., Reuben, A., Holliday, E. B., Smith, G. L., et al. (2024) · Journal of Clinical Oncology · doi:10.1200/jco.24.00081 · Cited by 93
Jagodinsky, J. C., Vera, J. M., Jin, W. J., Shea, A. G., Clark, P. A., Sriramaneni, R. N., Havighurst, T. C., Chakravarthy, I., Allawi, R. H., Kim, K., et al. (2024) · Science Translational Medicine · doi:10.1126/scitranslmed.adk0642 · Cited by 93
Zerbini, A., Pilli, M., Fagnoni, F. F., Pelosi, G., Pizzi, M. G., Schivazappa, S., Laccabue, D., Cavallo, C., Schianchi, C., Ferrari, C. I., et al. (2008) · Journal of Immunotherapy · doi:10.1097/cji.0b013e318160ff1c · Cited by 93
van den Heuvel, M. M., Verheij, M., Boshuizen, R. C., Belderbos, J. S. A., Dingemans, A. C., Ruysscher, D. D., Laurent, J., Tighe, R., Haanen, J. B. A. G., & Quaratino, S. (2015) · Journal of Translational Medicine · doi:10.1186/s12967-015-0397-0 · Cited by 93
Singh, A. K., Winslow, T. B., Kermany, M. H., Goritz, V., Heit, L., Miller, A., Hoffend, N. C., Stein, L. C., Kumaraswamy, L. K., Warren, G. W., et al. (2017) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-16-2946 · Cited by 93
Chang, X., Lu, X., Guo, J., & Teng, G. (2018) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2018.08.006 · Cited by 92
Enhancing CAR T-cell therapy through cellular imaging and radiotherapy
Minn, I., Rowe, S. P., & Pomper, M. G. (2019) · The Lancet Oncology · doi:10.1016/s1470-2045(19)30461-9 · Cited by 92
Radiotherapy and cGAS/STING signaling: Impact on MDSCs in the tumor microenvironment
Kho, V. M., Mekers, V. E., Span, P. N., Bussink, J., & Adema, G. J. (2021) · Cellular Immunology · doi:10.1016/j.cellimm.2021.104298 · Cited by 93
Kuiper, J. J. W., Prinz, J. C., Stratikos, E., Kuśnierczyk, P., Arakawa, A., Springer, S., Mintoff, D., Padjen, I., Shumnalieva, R., Vural, S., et al. (2023) · Annals of the Rheumatic Diseases · doi:10.1136/ard-2022-222852 · Cited by 92
From DNA Damage to Nucleic Acid Sensing: A Strategy to Enhance Radiation Therapy
Deng, L., Liang, H. L., Fu, S., Weichselbaum, R. R., & Fu, Y. (2016) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-14-3110 · Cited by 94
Césaire, M., Thariat, J., Candéias, S. M., Stefan, D., Saintigny, Y., & Chevalier, F. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19123793 · Cited by 94
Zhao, X., & Shao, C. (2020) · Cancers · doi:10.3390/cancers12102762 · Cited by 92
Radiotherapy and Immunotherapy for Head and Neck Cancer: Current Evidence and Challenges
Qian, J. M., & Schoenfeld, J. D. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2020.608772 · Cited by 91
Plumbing the sources of endogenous MHC class I peptide ligands
Yewdell, J. W. (2006) · Current Opinion in Immunology · doi:10.1016/j.coi.2006.11.010 · Cited by 91
Radiation therapy and the abscopal effect: a concept comes of age
Ng, J., & Dai, T. (2016) · Annals of Translational Medicine · doi:10.21037/atm.2016.01.32 · Cited by 91
Immunotherapy With Radiotherapy and Chemoradiotherapy for Cervical Cancer
Feng, C. H., Mell, L. K., Sharabi, A. B., McHale, M. T., & Mayadev, J. (2020) · Seminars in Radiation Oncology · doi:10.1016/j.semradonc.2020.05.003 · Cited by 90
HPV-induced oropharyngeal cancer, immune response and response to therapy
Vu, H. L., Sikora, A. G., Fu, S., & Kao, J. (2009) · Cancer Letters · doi:10.1016/j.canlet.2009.06.026 · Cited by 94
Combined Radiation Therapy and Immune Checkpoint Blockade Therapy for Breast Cancer
Hu, Z. I., Ho, A. Y., & McArthur, H. L. (2017) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2017.05.029 · Cited by 90
Clinical Evaluation of TRICOM Vector Therapeutic Cancer Vaccines
Madan, R. A., Bilusic, M., Heery, C., Schlom, J., & Gulley, J. L. (2012) · Seminars in Oncology · doi:10.1053/j.seminoncol.2012.02.010 · Cited by 84
Self-citationTaniguchi, H., Chakraborty, S., Takahashi, N., Banerjee, A., Caeser, R., Zhan, Y. A., Tischfield, S. E., Chow, A. T., Nguyen, E. M., Quintanal-Villalonga, À., et al. (2024) · Science Advances · doi:10.1126/sciadv.ado4618 · Cited by 89
Zhang, P., Darmon, A., Marill, J., Mohamed Anesary, N., & Paris, S. (2020) · International Journal of Nanomedicine · doi:10.2147/ijn.s250490 · Cited by 80
Ni, J., Zhang, Z., Ge, M.-J., Chen, J., & Zhuo, W. (2022) · Acta Pharmacologica Sinica · doi:10.1038/s41401-022-00953-z · Cited by 89
Building immunity to cancer with radiation therapy
Haikerwal, S. J., Hagekyriakou, J., MacManus, M. P., Martin, O. A., & Haynes, N. M. (2015) · Cancer Letters · doi:10.1016/j.canlet.2015.01.009 · Cited by 90
Norm- and hypo-fractionated radiotherapy is capable of activating human dendritic cells
Kulzer, L., Rubner, Y., Deloch, L., Allgäuer, A., Frey, B., Fietkau, R., Dörrie, J., Schaft, N., & Gaipl, U. S. (2014) · Journal of Immunotoxicology · doi:10.3109/1547691x.2014.880533 · Cited by 88
Erinjeri, J. P., Fine, G., Adema, G. J., Ahmed, M., Chapiro, J., den Brok, M. H., Durán, R., Hunt, S. J., Johnson, D., Ricke, J., et al. (2019) · Radiology · doi:10.1148/radiol.2019182326 · Cited by 87
Therapeutic strategies to remodel immunologically cold tumors
Wang, M., Wang, S., Desai, J., Trapani, J. A., & Neeson, P. J. (2020) · Clinical & Translational Immunology · doi:10.1002/cti2.1226 · Cited by 88
Jagodinsky, J. C., Jin, W. J., Bates, A. M., Hernandez, R. T., Grudzinski, J. J., Marsh, I. R., Chakravarty, I., Arthur, I. S., Zangl, L. M., Brown, R. J., et al. (2021) · Theranostics · doi:10.7150/thno.54881 · Cited by 87
MHC Class I Immunopeptidome: Past, Present, and Future
Yewdell, J. W. (2022) · Molecular & Cellular Proteomics · doi:10.1016/j.mcpro.2022.100230 · Cited by 87
Huang, J. C., Theelen, W. S. M. E., Belcaid, Z., Najjar, M., van der Geest, D., Singh, D., Cherry, C., Balan, A., White, J. R., Wehr, J., et al. (2025) · Nature Cancer · doi:10.1038/s43018-025-01018-w · Cited by 88
T lymphocytes and normal tissue responses to radiation
Schaue, D., & McBride, W. H. (2012) · Frontiers in Oncology · doi:10.3389/fonc.2012.00119 · Cited by 88
How Does Ionizing Irradiation Contribute to the Induction of Anti-Tumor Immunity?
Rubner, Y., Wunderlich, R., Rühle, P.-F., Kulzer, L., Werthmöller, N., Frey, B., Weiss, E.-M., Keilholz, L., Fietkau, R., & Gaipl, U. S. (2012) · Frontiers in Oncology · doi:10.3389/fonc.2012.00075 · Cited by 81
Radiation therapy to enhance tumor immunotherapy: a novel application for an established modality
Ko, E. C., & Formenti, S. C. (2019) · International Journal of Radiation Biology · doi:10.1080/09553002.2019.1623429 · Cited by 86
Newton, J. M., Hanoteau, A., Liu, H., Gaspero, A., Parikh, F., Gartrell, R. D., Hart, T. D., Laoui, D., Ginderachter, J. A. V., Dharmaraj, N., et al. (2019) · Journal for ImmunoTherapy of Cancer · doi:10.1186/s40425-019-0698-6 · Cited by 86
Radiation induces dynamic changes to the T cell repertoire in renal cell carcinoma patients
Chow, J. L., Hoffend, N. C., Abrams, S. I., Schwaab, T., Singh, A. K., & Muhitch, J. B. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2001933117 · Cited by 86
Combination Strategies to Optimize Efficacy of Dendritic Cell-Based Immunotherapy
van Gulijk, M., Dammeijer, F. F., Aerts, J. G. J. V., & Vroman, H. H. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.02759 · Cited by 87
The role of DNA damage repair (DDR) system in response to immune checkpoint inhibitor (ICI) therapy
Shi, C., Qin, K., Lin, A., Jiang, A., Cheng, Q., Liu, Z., Zhang, J., & Luo, P. (2022) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-022-02469-0 · Cited by 85
Irradiation and immunotherapy: From concept to the clinic
Salama, A. K. S., Postow, M. A., & Salama, J. K. (2016) · Cancer · doi:10.1002/cncr.29889 · Cited by 85
Immunotherapy and Immunotherapy Combinations in Metastatic Castration-Resistant Prostate Cancer
Bansal, D., Reimers, M. A., Knoche, E. M., & Pachynski, R. K. (2021) · Cancers · doi:10.3390/cancers13020334 · Cited by 85
Enhancing immune responses to tumor-associated antigens
Higgins, J. P., Bernstein, M. B., & Hodge, J. W. (2009) · Cancer Biology & Therapy · doi:10.4161/cbt.8.15.9133 · Cited by 85
Self-citationImmune Modulation and Stereotactic Radiation: Improving Local and Abscopal Responses
Zeng, J., Harris, T. J., Lim, M. K., Drake, C. G., & Tran, P. T. (2013) · BioMed Research International · doi:10.1155/2013/658126 · Cited by 85
Manukian, G., Bar‐Ad, V., Lü, B., Argiris, A. E., & Johnson, J. M. (2019) · Frontiers in Oncology · doi:10.3389/fonc.2019.00122 · Cited by 85
Stereotactic ablative radiotherapy for colorectal cancer liver metastasis
Wang, H., Li, X., Peng, R., Wang, Y., & Wang, J. (2020) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2020.06.018 · Cited by 84
Current status and advances of immunotherapy in nasopharyngeal carcinoma
Xu, J., Wei, X., Wang, Y., & Wang, F. (2022) · Therapeutic Advances in Medical Oncology · doi:10.1177/17588359221096214 · Cited by 84
Busato, F., Khouzai, B. E., & Mognato, M. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms231810211 · Cited by 84
Kamrava, M. R., Bernstein, M. B., Camphausen, K. A., & Hodge, J. W. (2009) · Molecular BioSystems · doi:10.1039/b911313b · Cited by 84
Self-citationPatel, R. B., Czapar, A. E., Fiering, S., Oleinick, N. L., & Steinmetz, N. F. (2018) · ACS Omega · doi:10.1021/acsomega.8b00227 · Cited by 84
Sharabi, A. B., Tran, P. T., Lim, M. K., Drake, C. G., & DeWeese, T. L. (2015) · PubMed · Cited by 84
Predictive biomarkers for immune checkpoint blockade and opportunities for combination therapies
Shen, H., Yang, E. S.-H., Conry, M., Fiveash, J. B., Contreras, C. M., Bonner, J. A., & Shi, L. Z. (2019) · Genes & Diseases · doi:10.1016/j.gendis.2019.06.006 · Cited by 84
In-situ tumor vaccination: Bringing the fight to the tumor
Pierce, R. H., Campbell, J. S., Pai, S. I., Brody, J., & Kohrt, H. E. K. (2015) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2015.1049779 · Cited by 82
Radiotherapy and immune checkpoints inhibitors for advanced melanoma
Filippi, A. R., Fava, P., Badellino, S., Astrua, C., Ricardi, U., & Quaglino, P. (2016) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2016.06.003 · Cited by 82
Procureur, A., Simonaggio, A., Bibault, J., Oudard, S. M., & Vano, Y. A. (2021) · Cancers · doi:10.3390/cancers13040678 · Cited by 82
Chavez, M., Silvestrini, M. T., Ingham, E. S., Fite, B. Z., Mahakian, L. M., Tam, S. M., Ilovitsh, A., Monjazeb, A. M., Murphy, W. J., Hubbard, N. E., et al. (2018) · Theranostics · doi:10.7150/thno.25613 · Cited by 82
Savage, T., Pandey, S., & Guha, C. (2020) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-18-3518 · Cited by 82
Metropulos, A. E., Munshi, H. G., & Principe, D. R. (2022) · eBioMedicine · doi:10.1016/j.ebiom.2022.104380 · Cited by 81
Philippou, Y., Sjoberg, H. T., Murphy, E. A., Alyacoubi, S., Jones, K. I., Gordon-Weeks, A. N., Phyu, S. M., Parkes, E. E., McKenna, W. G., Lamb, A. D. G., et al. (2020) · British Journal of Cancer · doi:10.1038/s41416-020-0956-x · Cited by 81
Cancer vaccines: Target antigens, vaccine platforms and preclinical models
Ruzzi, F., Riccardo, F., Conti, L., Tarone, L., Semprini, M. S., Bolli, E., Barutello, G., Quaglino, E., Lollini, P., & Cavallo, F. (2024) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2024.101324 · Cited by 81
Ionizing radiation effects on the tumor microenvironment
Portella, L., & Scala, S. (2019) · Seminars in Oncology · doi:10.1053/j.seminoncol.2019.07.003 · Cited by 82
Glioma Stem Cells as Immunotherapeutic Targets: Advancements and Challenges
Piper, K. J., DePledge, L., Karsy, M. J., & Cobbs, C. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.615704 · Cited by 80
Polysaccharide‐Based Stimulus‐Responsive Nanomedicines for Combination Cancer Immunotherapy
Li, Q., Liu, X., Yan, C., Zhao, B., Zhao, Y., Yang, L., Shi, M., Yu, H., Li, X., & Luo, K. (2023) · Small · doi:10.1002/smll.202206211 · Cited by 80
Immune mechanisms mediating abscopal effects in radioimmunotherapy
Rodriguez-Ruiz, M. E., Rodríguez, I., Leaman, O., López‐Campos, F., Montero, A., Conde-Moreno, A. J., Aristu, J., Lara, P. C., Calvo, F. Á., & Melero, I. (2018) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2018.12.002 · Cited by 80
Zebertavage, L., Alice, A. F., Crittenden, M. R., & Gough, M. J. (2020) · Scientific Reports · doi:10.1038/s41598-020-64408-3 · Cited by 80
Metadata
- Authors
- Reits, E. A., Hodge, J. W., Herberts, C. A., Groothuis, T. A., Chakraborty, M., K.Wansley, E., Camphausen, K., Luiten, R. M., de Ru, A. H., Neijssen, J., Griekspoor, A., Mesman, E., Verreck, F. A., Spits, H., Schlom, J., van Veelen, P., & Neefjes, J. J.
- Affiliations
- The Netherlands Cancer Institute (NL)
- 2Laboratory of Tumor Immunology and Biology
- National Institutes of Health (US)
- 4Department of Immunohematology and Blood Transfusion, Leiden University Medical Center, and Centre for Medical Systems Biology, 2333 2A Leiden, Netherlands
- Leiden University Medical Center (NL)
- ORCID
- Venue
- The Journal of Experimental Medicine
- Publisher
- Rockefeller University Press
- Published
- 2006-04-24
- Volume
- 203
- Issue
- 5
- Pages
- 1259-1271
- ISSN
- 0022-1007 (ISSN-L)
- 1540-9538
- PMC
- PMC3212727
- OpenAlex
- W2127733313
- Cited by
- 1,737
- References
- 53
- Citations by year
- 2026: 88 · 2025: 116 · 2024: 119 · 2023: 128 · 2022: 149 · 2021: 174 · 2020: 154 · 2019: 118 · 2018: 112 · 2017: 113 · 2016: 78 · 2015: 71 · 2014: 67 · 2013: 62 · 2012: 41
- FWCI
- 10.85
- Type
- journal article
- Language
- en
- Open access
- green
- europepmc.org
- Licence
- cc-by-nc-sa
- Locations
- The Journal of Experimental Medicine (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion, cc-by-nc-sa)
- PubMed Central (publishedVersion, cc-by-nc-sa)
- PubMed (publishedVersion)
- Data Archiving and Networked Services (DANS) (submittedVersion)
- Pure Amsterdam UMC (submittedVersion)
- Funders
- National Institutes of Health
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Immunotherapy and Immune Responses
- Health Sciences › Medicine › Oncology › Cancer Immunotherapy and Biomarkers
- Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
- Keywords
- radiotherapy, gamma irradiation, MHC class I expression, antigen presentation, protein degradation, mTOR signaling, translation (biology), cytotoxic T lymphocytes, cancer immunotherapy, colon adenocarcinoma
- MeSH terms
- Adenocarcinoma, Animals, Colonic Neoplasms, Dose-Response Relationship, Radiation, Gamma Rays, Humans, Immunotherapy, Mice, Transgenic, Peptides, Protein Kinases, Radiotherapy, T-Lymphocytes, Cytotoxic, Protein Biosynthesis, HLA-A2 Antigen, Gene Expression Regulation, Neoplastic, Antigen Presentation, Mice, TOR Serine-Threonine Kinases
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.